Tumor cells can evade chemotherapy by acquiring resistance to apoptosis. We investigated the molecular mechanism whereby malignant and nonmalignant mammary epithelial cells become insensitive to apoptosis. We show that regardless of growth status, formation of polarized, three-dimensional structures driven by basement membrane confers protection to apoptosis in both nonmalignant and malignant mammary epithelial cells. By contrast, irrespective of their malignant status, nonpolarized structures are sensitive to induction of apoptosis. Resistance to apoptosis requires ligation of ␤4 integrins, which regulates tissue polarity, hemidesmosome formation, and NFB activation. Expression of ␤4 integrin that lacks the hemidesmosome targeting domain interferes with tissue polarity and NFB activation and permits apoptosis. These results indicate that integrin-induced polarity may drive tumor cell resistance to apoptosis-inducing agents via effects on NFB.
Introduction
. This paradox suggests that, in some cases, ECM adhesion may foster tumor progression rather Apoptosis is essential for immune surveillance and for the effithan tumor inhibition (Tani et al., 1997; Pfohler et al., 1998) . cacy of tumor therapy (Costello et al., 1999; Rathmell and Interactions between tumor cell integrins and adhesion mole- Thompson, 2002) . Although considerable progress has been cules in the ECM microenvironment may drive the selection of treatment-resistant tumors (Nicolson, 1988; Singh et al., 1997 ; made toward understanding how apoptosis is executed at the cellular level (Adams and Cory, 1998; Thornberry and Lazebnik, Van Riet et al., 1998; Puduvalli, 2001) . However, the rate at which tumors can acquire resistance to treatment in vivo argues 1998), less is known about what regulates apoptotic decisions and how apoptotic agents could selectively target the tumor that mechanisms, functioning independently of genetic selection, must also operate to drive the genesis of apoptosis resis-tissues.
The site of tumor cell metastasis is influenced by the compo-tance in metastatic tumors. The tissue ECM may modify the responsiveness of tumors sition of the extracellular matrix (ECM) and the integrins expressed by the tumor cells (Pignatelli and Stamp, 1995) . Despite to exogenous apoptotic stimuli. Adhesion to ECM rapidly and reversibly modifies the responsiveness of myeloma and lung the fact that tumors overexpress ECM-degrading proteases, aggressive tumors often make excess basement membrane tumor cells to chemotherapeutic drugs (Damiano et al., 1999; Sethi et al., 1999) . Tumor cells selected for their drug resistance (BM) and have abundant ␤4 integrins (Tagliabue et al., 1998;  
S I G N I F I C A N C E
Here we used a 3D model of nonmalignant and malignant human breast epithelial cells that could be repeatedly and reversibly organized into polarized tissue-like structures to study how normal tissues and some tumor cells resist apoptotic cell death by chemotherapeutic agents and immune regulators. We show that, regardless of the genetic makeup, the rate of growth, or the malignant status, resistance correlates with ECM composition, hemidesmosome-dependent polarity, and NFB activation. Our model sheds light on the endogenous activation of this pathway in epithelial tissues. These data indicate the critical importance of tissue architecture in resistance to apoptosis, have important implications for how tumor cells may become dormant, and offer possible chemotherapeutic strategies. CANCER CELL : SEPTEMBER 2002 · VOL. 2 · COPYRIGHT  2002 CELL PRESS 205 Apoptotic labeling indices calculated for S-1 and T4-2 cells treated with Trail peptide (1 g/ ml), anti-FAS mAb (IgM CH-11, 2 g/ml), TNF-␣ (100 nM), etoposide (50 M), cytochalasin B (1 M), or paclitaxol (120 nM). Cells were treated (A) as monolayers on a thin coat of collagen I for 24 hr or (B) as 3D structures in rBM for 96 hr.
Results are the mean Ϯ SEM of 3-5 separate experiments, each with duplicates or triplicates.
in monolayer cultures develop changes in cell adhesion and emergence of multidrug-resistant tumors by influencing cell death regulators through effects on cell adhesion-directed tis-integrin expression (Nista et al., 1997; Narita et al., 1998) . Tumor cells grown as three-dimensional (3D) multicellular spheroids sue architecture. rapidly acquire and sustain a multidrug-resistant phenotype in response to acute drug treatment (Durand and Olive, 2001; Results Kerbel 1994) , exhibit modified adhesion (Hauptmann et al., 1995; St. Croix et al., 1998) , and secrete ECM proteins (Santini Studies using cells in two-dimensional (2D) monolayers have demonstrated clearly that deregulated expression of apoptosis-and Rainaldi, 1999) . This implies that tissue organization, cell adhesion, and the ECM may synergistically generate apoptosis mediating or -inhibiting molecules can confer resistances to cytotoxic drugs and death receptor ligands (Kaufmann and resistance in metastatic tumors. We showed previously that ECM-induced tissue architecture can override the proliferative Earnshaw, 2000; Zhang et al., 2000) . Clinical studies in patients, however, often have failed to verify these observations. In con-and invasive malignant phenotype, but that reversion is dependent upon the 3D tissue microenvironment (Weaver et al., 1997;  trast, excellent correlation is observed between resistances to drugs in three-dimensional (3D) cultures of primary cancer cells Wang et al., 1998) . Because reversion of the malignant phenotype and polarity are associated with recalcitrance to growth and immortalized malignant cells and tumors in vivo (Desoize and Jardillier, 2000) . Because we have observed previously that factor stimulation, we have now hypothesized that the ECM, via cooperative interactions between integrins, the cytoskele-cells in 2D and 3D contexts integrate signaling pathways differently (Wang et al., 1998; Bissell et al., 1999; Bissell and Radisky, ton, and 3D tissue organization, dictates apoptosis inducibility in mammary epithelial cells (MECs).
2001), we asked whether 3D tissue architecture could alter apoptotic resistance to drugs, and if so, how? We therefore de-To show this, we used the HMT-3522 MEC model of breast cancer progression (Briand et al., 1996; Weaver et al., 1996) . signed experiments to investigate the link between cell adhesion and 3D tissue architecture and the genesis of the apoptosis-This tumor cell series was established from a reduction mammoplasty of a woman with a nonmalignant breast lesion. Contin-resistant tumor phenotype. ued passage and growth factor withdrawal led to the spontaneous generation of tumorigenic cells (Briand et al., 1996) . We A differentiated tissue structure is resistant to apoptosis induction used the nonmalignant S-1 cells at passages 50-70 ("normal"; S-1) and their tumorigenic progeny at passages 238-245 (T4-2).
We asked whether interactions with BM modulate the sensitivity of MECs to apoptotic stimuli in 3D cultures, and if malignant In the present study we asked whether BM signaling via integrins regulates apoptosis resistance in 3D structures of MECs, and transformation altered this responsiveness. We measured the apoptotic sensitivity of S-1 and malignant T4-2 MECs to apo-if so, how. We determined that the BM component laminin can drive resistance to apoptosis induced by immune modulators ptotic stimuli in 2D and 3D. S-1 and T4-2 MECs, grown as 2D monolayers on a thin coat of collagen I, exhibited comparable and cytotoxic drugs by driving polarization via ␣6␤4 integrincytoskeletal interactions and NFB activation. Our data illustrate apoptotic responsiveness regardless of the kind of apoptotic agent used. These included ligation of receptors for tumor ne-how the tissue microenvironment could rapidly influence the S-1 acini produced within rBM were treated with E-cadherin function-blocking mAb (HECD-1; 25 g/ml rBM) to perturb polarity. T4-2 structures within rBM were treated with ␤1 integrin inhibitory mAb (clone AIIB2; 1:50 ascites/ml rBM) to restore polarity. A: Confocal microscopy of nuclei (propidium iodide), F-actin (FITC-phalloidin), ␤catenin (Texas red), ␤4 integrin (Texas red), and laminin-5 (FITC) fluorescence. Note that S-1 and reverted T4-2 acini exhibit cortically organized filamentous F-actin, cell-cell junction-localized ␤-catenin, basally localized ␤4 integrins, and basally secreted laminin-5. Contrast with the S-1 disrupted and T4-2 disorganized structures. B: Apoptotic labeling indices calculated for cells grown as described in A, and treated with TNF-␣ (100 nM), etoposide (50 M), or anti-FAS mAb (2 g/ml) for 96 hr. Results are mean Ϯ SEM of 3-5 separate experiments, each with duplicates or triplicates. C: BrdU labeling indices under conditions described in B. Results are mean Ϯ SEM of three separate experiments of 200-400 cells per experiment. All cultures were analyzed after 10 days inside the rBM. Bar equals 10 m.
crosis factor (TNF-␣), Trail, Fas, or treatment with the microtu-to nonmalignant MEC acini; however, this mechanism was absent or was no longer functioning after malignant transformation bule reagent paclitaxol, the topoisomerase II inhibitor etoposide, or the actin cytoskeletal disruptor cytochalasin B (Figure 1 ).
( Figure 1B ). Nonmalignant MECs embedded in reconstituted BM (rBM) formed growth-arrested 3D organoids (acini), whereas malig-A polarized mammary tissue structure is resistant nant MECs continued to proliferate to form nonpolar, multicelluto apoptosis induction To determine whether the differential sensitivity in nonmalignant lar, and disorganized 3D aggregates (Petersen et al., 1992; Weaver et al., 1997) . The rBM conferred apoptosis resistance and malignant cells in 3D was a direct function of genetic nin-5 and ␤4 integrin at their basal surface ( Figure 2A ) and were resistant to apoptosis by all three apoptotic agents tested ( Figure 2B ). Conversely, disruption of polarity by treating S-1 cells with a function-blocking anti-E-cadherin mAb (Figure 2A ; Day et al., 1999) inside the rBM resulted in clusters of cells with disordered filamentous actin, dispersed ␤4 integrin, and intracellular and randomly secreted laminin-5, similar to the disorganized T4-2 colonies (Figure 2A ). The disorganized S1 cells now became very sensitive when the acinar polarity was compromised ( Figure 2B ).
BM-induced tissue polarity is necessary for apoptosis resistance regardless of growth status
Cytotoxic drugs induce apoptosis in target cells based upon their capacity to promote cell-cycle arrest (Roninson et al., 2001; Hurley, 2002) . Because the formation of tissue polarity and apoptosis resistance was also associated with a substantial reduction in cell growth ( Figure 2C ), we asked whether growth arrest was sufficient for apoptosis resistance. S1 cells form polarized, growth-arrested structures within 3D rBM, whereas they growth arrest within 3D collagen I gels but are not polarized (Lelievre et al., 1998; Gudjonsson et al., 2002) . In addition, S-1 cells that overexpress EGF-R (Wang et al., 1998) continue to proliferate but maintain basal polarity within rBM ( Figure 3A ). All three groups maintain adherens junctions as shown by ␤-catenin localized at cell-cell junctions ( Figure 3A) . A comparison of apoptotic response indicated that only those MECs that were basally polarized, as indicated by deposition of an endogenous BM ( Figure 3A ), were resistant to apoptosis following treatment with TNF-␣, Fas mAb, or etoposide, whether growth-arrested or proliferating ( Figures 3B and 3C ). In contrast, growth-arrested but nonpolarized S-1 cells underwent apoptosis.
To investigate whether it is the presence of rBM molecules per se or whether rBM-induced polarity is required for protection, we grew S-1 cells as 3D nonpolar spheroids within collagen I gels or as 3D polar acini in rBM. In parallel, we liberated some MEC 3D spheroids by collagenase treatment, suspended them in polyHEMA-coated dishes, and then overlaid them with serumfree medium supplemented with either BSA or rBM proteins. All of these tissue structures were growth arrested (see Figure  3B ) and showed adherens junctions as assessed by ␤-catenin ( Figure 4A ). Apoptosis could be readily induced in the S-1 nonpolar spheroids in collagen I gels, but once exposed to rBM, they resembled polarized S-1 acini with basally localized ␤4 and ␣6 integrins and laminin-5, and they acquired apoptosis resistance ( Figure 4B ). 
BM-induced tissue polarity regulates NFB activation to drive apoptosis resistance
NFB is activated early during neoplastic transformation of the expression and stability of apoptosis regulators (Tanaka et al., mammary gland in rodents and may play an 2000; Tergaonkar et al., 2002) . Accordingly, we investigated the important role also in the pathogenesis (Sovak et al., 1997) and relationship of NFB p65 activation to BM-induced polarity and metastasis of human breast cancers (Nakshatri et al., 1997) . apoptosis resistance. Within 1 hr of treatment of polarized S-1 Activated NFB is linked to repression of apoptosis during mamacini with TNF-␣, Trail, or etoposide, nuclear localization of mary involution in mice and increased survival of murine mam-NFB B p65 increased measurably ( Figure 5A ). When we used mary epithelial cells in culture (Clarkson et al., 2000) . NFB the multicatalytic proteasome inhibitor MG 132 or expressed a activation also drives resistance to chemo-and radiation thermutant IB␣, which is resistant to proteolytic degradation, nuclear translocation of p65 did not occur (data not shown) and all apy (Baldwin, 2001 ; Baeuerle and Baltimore, 1996) and modifies Figure 6. ␣6␤4 integrin directs apoptosis resistance in 3D mammary organoids A: Apoptotic labeling indices calculated for S-1 cells grown in collagen I and preincubated with function-blocking mAb against ␣3 integrin (clone P15B), ␤1 integrin (clone AIIB2), ␣6 integrin (clone GoH3), ␤4 integrin (clone ASC 3), or an isotype-specific IgG control for 30 min, overlaid with rBM and then treated in suspension culture with TNF-␣ (100 M) for 96 hr. Results are the mean Ϯ SEM of 4-8 separate experiments, all in triplicate. B: Apoptotic labeling indices calculated for S-1 cells grown in collagen I gels following ligation and clustering of ␤1 or ␤4 integrin or a MHC cell surface molecule for 1 hr and then treated with Trail (1 g/ml) for 96 hr. Results are the mean Ϯ SEM of 2-6 separate experiments, each with duplicates. C: Apoptotic labeling indices calculated for S-1 vector or tailless ␤4 integrin-expressing cells grown in rBM for 10 days and treatment with etoposide (50 M), Fas mAb (1 g/ml), or Trail (1 g/ml) for 96 hr. Results are the mean Ϯ SEM of three separate experiments. D: Immunofluoresence of HD-1, BP180, ␣6 integrin, ␤4 integrin, collagen IV, and laminin-5 (Texas red) in S-1 control versus S-1 expressing tailless ␤4 integrin (GFP). Bar equals 10 M. three of these agents induced apoptosis ( Figure 5B ). In contrast, apoptosis-sensitive S-1 spheroids isolated from collagen I gels with function-blocking mAb to ␣2, ␣3, ␣6, ␤1, or ␤4 integrin ceramide, which fails to induce nuclear translocation of NFB, induced death in S-1 acini under all conditions ( Figures 5A and 5B) .
or control IgG. The structures were suspended in polyHEMAcoated dishes in serum-free media supplemented with either These data show that BM-induced polarity modulates endogenous NFB activation in epithelial acini and is one mechanism mediating BSA or rBM. The spheroids treated with rBM, but not BSA, that were challenged with TNF-␣ in the presence of mAb directed BM-induced apoptosis resistance in MEC acini.
against ␤1, ␣2, or ␣3 integrins were viable and intact, even after 96 hr of incubation ( Figure 6A ), and showed nuclear transloca-␣6␤4 integrin directs apoptosis resistance in 3D mammary organoids tion of NFB (data not shown). In contrast, cells in the rBMtreated spheroids incubated with blocking mAbs to ␣6 or ␤4 To address which laminin receptor is necessary for induction of polarity and apoptosis resistance, we incubated nonpolar, integrins failed to establish polarity, did not activate NFB (data not shown), and showed significantly increased apoptosis when challenged with TNF-␣ for 96 hr ( Figure 6A ). Because S-1 MECs do not express ␣6␤1 integrin (data not shown), these results indicate that ␣6␤4 integrins, but not ␣2␤1 or ␣3␤1 integrins, participate in regulating BM-directed apoptosis resistance in polarized acini.
To establish whether ligation of ␤4 integrins was sufficient to protect the nonpolarized spheroids from apoptosis induction, we ligated and clustered their ␤1 or ␤4 integrins or MHC molecules with mAbs that were crosslinked to magnetic beads. The integrin-activated 3D MEC structures were suspended in poly-HEMA-coated dishes in serum-free medium. mAb-bead-mediated ligation of ␤4, but not ␤1 integrins, protected the MEC spheroids from apoptosis induction ( Figure 6B ). Conversely, when S-1 cells expressing a GFP-labeled tailless ␤4 integrin were embedded in rBM to form growth-arrested structures, NFB did not translocate to the nucleus following drug treatment (data not shown) and cells did not develop polarity ( Figure 6D ). These structures showed disrupted hemidesmosome formation, as indicated by randomly dispersed type 1 hemidesmosome protein, HD-1, and bullous pemphigoid antigen 180 (BP180; Figure 6D ). Loss of tissue polarity and NFB activation in these growth-arrested structures was associated with enhanced sensitivity to apoptosis induced by etoposide, Trail, and Fas receptor ligation ( Figure 6C) . Thus, the ability of ␤4 integrins to drive tissue polarity is essential for activation of NFB and apoptosis resistance.
Disrupting hemidesmosome formation perturbs BMdirected tissue polarity, inhibits NFB activation, and permits induction of apoptosis in 3D acini
An important function of ␤4 integrin is to functionally link the cytoskeleton to hemidesmosomes. Accordingly, we investigated the role played by hemidesmosomes in induction of polarity, NFB activation, and apoptosis resistance in MEC acini. T4-2 nonpolar spheroids in rBM had sparsely dispersed hemidesmosomes (1 hemidesmosome/2 m plasma membrane), of which Ͼ90% were immature type II hemidesmosomes, disorganized ␤4 integrin, a sparse random distribution of HD-1, and predominantly cytosolic NFB p65 (Figure 7) . In contrast, T4-2 cells in rBM, treated with a function-blocking ␤1 integrin mAb but not nonspecific rat IgGs, reverted to polarized acini ( Figure  7 ; see also Figure 2A ). The polarized, reverted T4 structures had basally organized ␤4 integrin and HD-1, increased hemidesmosomes (2 hemidesmosomes/3 m plasma membrane) of which Ͼ60% were mature type I hemidesmosomes and nuclear (Figure 7) . These observations estabcreased levels of mature hemidesmosomes and constitutive activation of NFB lish an association between ␤4 integrin-directed tissue polarity, hemidesmosomes, and BM-induced apoptosis resistance.
T4-2 cells were grown inside rBM with control mAb or were reverted with ␤1 integrin inhibitory mAb (AIIB2) and were analyzed after 12 days by transmis-Several amino acid residues in the connecting segment that sion electron microscopy (TEM) and immunofluorescence. Both structures resides between the four type-III fibronectin-like modules, toexpressed the hemidesmosome proteins ␤4 integrin and HD-1 and conward the C terminus, are critical for targeting ␤4 integrin to tained hemidesmosomes; note, however, they are less abundant in the hemidesmosomes ( Figure 8A ). To test the involvement of hemi-T4-2 control spheroids (1/2 m plasma membrane), and of these, 90% are immature type II structures. Hemidesmosomes are more abundant in the desmosomes, S-1 cells were transfected with one of the follow- or untagged constructs. Pooled stable populations of S-1 cells transfected with the connecting segment deleted ␤4 or wildtype ␤4 integrin showed uniform expression of tagged RFP protein ( Figure 8C ) and increased total ␤4 integrin expression compared to S-1 vector controls ( Figure 8B ). All cells in 3D to most receptor-linked and many chemical stimuli. This phenotype requires ␤4 integrin to mediate hemidesmosome formation rBM assembled adherens junctions judged by localization of ␤-catenin ( Figure 8E ). Expression of the ␤4 integrin with the and to facilitate NFB activation. In support of these results, ␤4 integrin null keratinocytes exhibit reduced viability in response connecting segment deleted should act as a dominant negative by competing with the endogenous, wild-type ␤4 integrin to to an exogenous mechanical stress in vivo (Dowling et al., 1996) , and targeted disruption of the LAMA3 gene in mice compro-disturb hemidesmosome organization and perturb cytoskeletal organization. S-1 cells transfected with mutant ␤4 integrin con-mises keratinocyte survival (Ryan et al., 1999) . Similarly, ␤1 and ␤4 integrins activate NFB to maintain survival during T cell sistently formed structures with dispersed, faint HD-1; with patchy, sparsely distributed BP180; with cytosolic, nonpolarized development (Fiorini et al., 2000; Scupoli et al., 2000) . But how do tumor cells evade apoptotic therapy and what ␤4 integrin; and with randomly secreted laminin-5, indicating that disrupting hemidesmosome-cytoskeletal structures per-is the link to polarity? Our data suggest that epithelial tumors that express ␤4 integrins have the potential to acquire resistance turbed polarity ( Figure 8E) . In contrast, vector control or S-1 cells infected with wild-type ␤4 integrin were polarized with to exogenous death stimuli if they are given the appropriate spatial and biochemical cues from the microenvironment. The intense staining for HD-1 protein and punctate basal BP180 ( Figure 8E ). Moreover, perturbing hemidesmosome organization T4-2 breast tumor cells express ␤4 integrin and are sensitive to induction of apoptosis when they are grown in both two-in the 3D MEC structures with mutant EGFP-tagged ␤4 integrin reduced NFB activation and led to a significant enhancement dimensional and three-dimensional cultures. However, they acquire an apoptosis-resistant phenotype when they recapitulate in apoptosis sensitivity (Figures 8D and 8F) . These observations establish that ligation of ␣6␤4 integrins, formation of mature a three-dimensional, polarized architecture accompanied with endogenously activated NFB p65. These findings provide a hemidesmosomes, and activation of NFB p65 are linked to BM-directed tissue polarity and resistance to apoptosis.
rationale for a number of previous reports in the literature. Aggressive and metastatic breast tumor cell lines express ␤4 integrins (Taylor-Papadimitriou et al., 1993; Jones et al., 1997) . Fur-Discussion thermore, the highly metastatic, ␣6␤4 integrin-positive breast epithelial cell line MDA MB-231 rapidly and reversibly acquires These studies emphasize the important contribution of the tissue microenvironment and tissue architecture both in the mediaa multidrug apoptosis-resistant phenotype when grown in three tion of normal breast tissue viability as well as in the generation dimensions (Graham et al., 1994; Kerbel et al., 1996; Croix of the apoptosis-resistant phenotype of breast tumors. Our data et al., 1998) . The data are also consistent with clinical reports stress the relevance of recapitulating cellular context when atthat individuals expressing both BM proteins and ␤4 integrins in tempting to delineate the mechanisms underlying cell behavior. their primary tumors have the poorest prognosis among breast By taking advantage of the mammary epithelial tumor progrescancer patients (Tagliabue et al., 1998) and that breast tumors sion model, HMT-3522, and 3D assays in rBM or collagen-I gels, frequently show increased expression of NFB-regulated genes we were able to determine how nonmalignant and tumorigenic such as survivin (Tanaka et al., 2000) . A recent study showed breast epithelial cells could become resistant to apoptosis. The that more than 60% of primary breast tumor tissues express studies described here show that tissue architecture regulates high levels of both ␤4 integrin and laminin-5 (Davis et al., 2001 ) sensitivity to exogenous apoptotic stimuli and that this effect and more than 50% of dormant, metastatic cells isolated from is mediated via integrin-cytoskeletal associations and activation the bone marrow of breast cancer patients express ␣6 and/or of NFB. Laminin-induced ligation of ␤4 integrin directs tissue ␤4 integrins (Putz et al., 1999) . Furthermore, deregulated NFB polarity and promotes resistance to apoptosis in both nonmalighas been implicated as an important prognostic indicator in nant and malignant breast epithelial structures, regardless of primary and metastatic breast tumors (Nakshatri et al., 1997; growth status. The apoptosis resistance depends upon the 3D Sovak et al., 1997; Kim et al., 2000) , underscoring the potential organization of the acini and is functionally linked to ␤4 integrinrelevance of our present studies to tumor pathology. directed hemidesmosome formation and NFB activation. Thus, Our model suggests that integrin-directed tumor architecintegrin-laminin interactions not only initiate signals essential ture may constitute a prognostic indicator of future tumor behavfor cell growth, viability, and functional differentiation (Streuli et ior and apoptosis sensitivity. The major event regulating tumor al., 1991; Boudreau et al., 1995; Howlett et al., 1995) , but also metastasis is survival of the tumor cell in the distant site (Wong protect mammary cells that are organized into tissue-like strucet al., 2001) . Accordingly, our data may explain why tumors tures from exogenous apoptotic cues. The unit structure of the preferentially colonize selected tissues. In addition to providing tissue thus emerges as an important determinant of normal the soluble factors and blood flow dynamics deemed necessary tissue homeostasis .
for promoting the dissemination of metastatic tumor cells (Taylor The presence of hemidesmosomes in epithelial tissues staet al., 2000) , viable sites for tumor metastasis may also provide bilizes attachments to the underlying BM (Jones et al., 1998) .
the appropriate ECM, microenvironmental, and spatial informa-␣6␤4 integrins play a diverse role in normal epithelial physiology tion critical for tumor cell survival. (Borradori and Sonnenberg, 1999) 
by acting as laminin receptors
Experimental procedures that interact with intermediate filaments via long cytoplasmic tails (Spinardi et al., 1995) . This facilitates branching morpho-Substrates and antibodies genesis (Stahl et al., 1997), cell proliferation (Mainiero et al., The material used were as follows: commercial EHS matrix (Matrigel, Col-1997) , and migration (Goldfinger et al., 1999) . Here we show laborative Research) for the rBM assays; Vitrogen (Vitrogen 100, Celtrix that ligand-activated ␤4 integrin is involved directly in induction Laboratories; bovine skin collagen I), 3 mg/ml, for coating culture dishes; of tissue polarity in mammary epithelial acini and in modulating Cellagen Solution AC-5, 0.5% (ICN Biomedical, Inc.) for the 3D collagen I assays; and poly HEMA, 6 mg/ml (Sigma Chemicals) for the cell suspension a program that leads to the acquisition of apoptosis resistance studies. Antibodies used were: collagen IV, clone PHM-12 (Biogenex); lami-be inhibited by prior treatment with the caspase inhibitors YVAD-CHO or nin-5 ␣3 chain specific, clone BM165 (gift of M.P. Marinkovich, Stanford;
DEVD-CHO (1 M; BioMol Research Laboratories Inc.). Rousselle et al., 1991) ; ␣6 integrin, clones J15B (gift of C. Damsky, UCSF) and GoH3 (Chemicon International); ␣2 integrin, clone 10G11, and ␣3 integ-BM overlay assay and integrin inhibition studies rin, clone P15B (Chemicon International); ␤1 integrin, clones AIIB2 (gift of To assay for effects of rBM overlay on multicellular structures, cells were C. Damsky, UCSF) and TS2-16 (gift of M. Hemler, Harvard); ␤4 integrin, grown in collagen I gels to form spheroids, growth-arrested by removal of rabbit sera, and clones 3E1, ASC-3, and ASC-8 (Chemicon International); EGF for 24 hr, collagenase-liberated, and suspended in polyHEMA-coated BP180, rabbit sera J17 (J. Jones, Northwestern); HD-1, clone 121 (gift of K.
dishes in H14 media supplemented with either BSA or rBM proteins (2 Owaribe, Graduate School of Human Informatics, Okazaki, Japan; Okumura mg/ml). To inhibit integrin function, the 3D multicellular structures were et al., 1999); ␤-catenin, clone 14 (Transduction Laboratories); FAS receptor, preincubated with ␣2 integrin (4-16 g IgG/ml); ␣3 integrin (1:25-1:100 clones IgM CH-11 (MBL Co., Ltd.) and CD95 (Immunotech, Inc.); E-cadherin ascites/ml); ␣6 integrin (4-12 g IgG/ml); ␤1 integrin (1:25-1:100 ascites/ml); clone HECD-1 (Zymed); NFB p65, rabbit sera (Santa Cruz); cytokeratin 18, ␤4 integrin (4-16 g IgG/ml); or IgG isotype matched control mAb (4-16 g clone RCK106 (Transduction Laboratories); human MHC class I clone W6.32 IgG/ml). (Sigma); and actin, FITC-conjugated Phalloidin (Molecular Probes), fluorescein-and Texas red-conjugated, nonconjugated anti-mouse and anti-rat, Antibody-conjugated beads and integrin activation studies and nonspecific rat and mouse IgGs (Jackson Laboratories). The multicata-Monoclonal anti-human ␤1-integrin (TS2-16), ␤4-integrin (3E1), human MHC lytic proteosome inhibitor MG132 (5 mM stock in DMSO; Calbiochem) was class I (W6.32), or nonspecific IgG control mAb was covalently attached to used at 0.5-5.0 M. magnetic porous glass beads (5 M) by hydrazide crosslinking (CPG Inc.). Briefly, IgG protein was diluted (200 g/ml; 100 g total IgG), dialyzed Cell culture overnight in oxidation buffer (100 mM sodium acetate, 150 mM sodium The HMT-3522 MECs were grown and manipulated in 2D and 3D as dechloride [pH 5.5]), and then activated by periodate treatment (10 mM sodium scribed (Petersen et al., 1992; Weaver et al., 1997) . Phenotypic reversion of periodate). After quenching (50% glycerol), mAb was dialyzed into coupling T4-2 cells, using ␤1 integrin function-blocking mAb, and disruption of S-1 buffer (100 mM sodium acetate, 150 mM sodium chloride [pH 4.5]) and morphogenesis, using the E-cadherin function-blocking mAb, were exactly linked to prewashed MPG hydrazide beads, capped (67 mM glyceraldehyde, as described (Weaver et al., 1997; Wang et al., 1998) .
in coupling buffer), washed, and stored in buffer (PBS: 138 mM sodium chloride, 2.7 mM potassium chloride, 8.1 mM disodium phosphate, 1.2 mM Indirect immunofluorescence analysis and image acquisition potassium phosphate, 0.5 mM magnesium chloride, 0.1% Tween 20). To Cells were either directly fixed using 2% paraformaldehyde or in 1:1 methamonitor for apoptosis resistance induced by integrin activation in 3D sphenol:acetone or 100% methanol, or first extracted in situ using CSK buffer roids, prewashed (10 ϫ DMEM:F12) mAb crosslinked beads (1 g IgG/2 ϫ (50 mM HEPES, 300 mM sucrose, 100 mM KCl, 5 mM MgCl, 5 mM EDTA, 10 5 beads/10 5 cells) were preincubated with suspensions of collagenase-0.5% Triton X-100, containing 10 g/ml leupeptin, 10 g/ml pepstatin, 1 mM liberated 3D collagen I structures followed by incubation with the apoptosis-Pefabloc [Boehringer Mannheim], 10 g/ml E64, 25 g/ml aprotinin, 0.5 mM inducing agent. benzamidine, 1 mM sodium orthovanadate, and 20 mM sodium fluoride) and subsequently fixed. In some experiments, cultures were embedded in Electron microscopy analysis sucrose and frozen in Tissue-Tek OCT compound (Miles Laboratories), and Cells in rBM were fixed for a minimum of 30 min (2% glutaraldehye in 0.1 5 m frozen sections were prepared for immunostaining. Cell samples were M sodium cacodylate buffer [pH 7.2]), washed three times in 0.1 M sodium incubated with primary mAbs followed directly by either FITC-or Texas redcacodylate buffer, postfixed (1% OsO 4 containing 0.8% potassium ferricyaconjugated secondary Abs. Nuclei were counterstained with diaminophenylnide), stained with uranyl acetate, dehydrated in ethanol, and embedded in indole (DAPI, Sigma) or propidium iodide (Sigma). Cells were visualized using Epon-Araldite resin (Tousimis Corp.). Thin sections of embedded material a Bio-Rad MRC 1024 laser scanning confocal microscope attached to a were stained with lead nitrate and sodium citrate and viewed at 60 kV in a Nikon Diaphot 200 microscope. All immunofluorescence images were re-JEOL 100CX electron microscope (JEOL USA). corded at 120ϫ magnification.
Preparation of MECs expressing mutant ␤4 integrin Analysis of cell growth and the IB␣ mutant
The proliferation rate of cells was measured by assaying BrdU incorporation S-1 nonmalignant HMT-3522 cells were transfected with mutant ␤4 integrin using a commercially available labeling and detection kit (Boehringer Mannconnecting segment deleted and pcDNA 3.1 plasmid DNA using LipofectAMheim). The BrdU-labeling index was determined by scoring the BrdU-positive INE (GIBCO-BRL) or infected with GFP-tagged tailless ␤4 integrin or RFPcells and expressing this as a percentage of total cell number, estimated tagged connecting segment mutant or wild-type ␤4 integrin, or mutant IB␣ by counting the number of nuclei visualized by DAPI staining (200-400 cells).
(P. Khavari, Stanford; Seitz et al., 2000) , or untagged wild-type or mutant ␤4 integrin retroviral supernatant. Vector controls were prepared by transfecting Induction and analysis of apoptosis with plasmid 3.1 pcDNA, or GFP, RFP, or empty retroviral vector. Resistant Apoptosis was initiated by direct receptor trimerization using the FAS recep-␤4 integrin or vector control cells were selected using G418 (plasmid) or tor antibody IgM Ch-11 (1-2 g/ml); by receptor ligation with CD95 (1-2 blasticidin (retrovirus), whereas experiments conducted using the IB␣ mug/ml) followed by secondary mAb-induced clustering; and by treatment tant were done using nonselected pooled cell populations. with recombinant, purified Trail (Apo2L, 1-4 g/ml; BioMol Research Laboratories Inc.), recombinant TNF-␣ (10-100 nM; R&D Systems Inc.), the topo-Flow cytometry isomerase II inhibitor, etoposide (10-100 M in DMSO; TopoGen Inc.), the Cells grown as 2D monolayers were isolated, and nonspecific binding was microtubule agent paclitaxol (20-120 nM; Sigma), the actin microfilament blocked (60 min Dulbecco's PBS, 1% bovine serum albumin). They were drug cytochalasin B (1-2 g/ml; Sigma), the membrane permeable then incubated with saturating concentrations of primary mAb and washed N-acetylsphinogine analog C2-ceramide (0.5-5 M; BioMol), or the memthree times and labeled with fluorescein isothiocyanate (FITC)-conjugated brane-permeable nonactive N-acetylsphinogine analog C2-dihydroxceragoat immunoglobulin. Stained cells were washed three times and immedimide (0.5-5 M; BioMol). Screening assays for apoptosis included Live/ ately analyzed on a FACScan (Becton Dickinson). Dead Assay (Molecular Probes), active caspase 3 detection and cleavage of PARP by immunoblot analysis, and increased expression of annexin V in Immunoblot analysis treated cells (Pharmingen). After initial screening, routine assay for apoptosis To assess total ␤4 integrin levels, pooled populations of ␤4 integrin and in intact fixed cells or cryosections used a commercially available in situ vector control transfected or infected pooled cell populations were lysed in apoptosis kit (Boehringer Mannheim). The apoptotic labeling index was cal-RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM sodium chloride, 1% NP-40, culated as cells positive for FITC-labeled 3ЈOH DNA ends as a percentage 0.5% deoxycholate, 0.2% SDS containing 20 mM sodium fluoride, and 1 mM of the total number of cells scored (200-400 cells). In some experiments, cell death by apoptosis was confirmed by showing that DNA cleavage could sodium orthovanadate, and a cocktail of protease inhibitors). Equal amounts and radiotherapy modulated by the three-dimensional architecture of solid of protein were separated on nonreducing SDS-PAGE gels, immunoblotted, tumors and spheroids. Methods Cell Biol. 64, 211-233. and detected with an ECL system (Amersham Pharmacia BioTech).
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